Canadian Consensus Conference on Dementia: A physician's guide to using the recommendations

CMAJ. Canadian Medical Association Journal

Volumn 160, Issue 12, 1999, Pages 1738-1742

  Patterson, Christopher J S ^a,h   Gauthier, Serge ^b   Bergman, Howard ^c   Cohen, Carole A ^d   Feightner, John W ^e   Feldman, Howard ^f   Hogan, David B ^g  

^a MCMASTER UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; DEMENTIA; EVIDENCE BASED MEDICINE; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SHORT SURVEY;

EID: 0033564919     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Canadian Study of Health and Aging Working Group. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 1994;150:899-913.
2. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ 1999;160(12Suppl):S1-S20.
3. American Psychiatric Association. Delirium, dementia and other cognitive disorders. In: Diagnostic and statistical manual of mental disorders (DSM IV). 4th ed. Washington: The Association; 1994. p. 134.
4. Some drugs which cause psychiatric symptoms. Med Lett 1998;40(1020):21-4.
5. Folstein MR, Folstein SE, McHugh PR. "Mini-mental state": A practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
6. Freter S, Bergman H, Gold S, Chertkow H, Clarfield AM. Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort. CMAJ 1998;159:657-62.
7. Heyman A, Peterson B, Fillenbaum G, Pieper C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) part XIV: Demographic and clinicial predictors of survival in patients with Alzheimer's disease. Neurology 1996;46:656-60.
8. Shea C, Macknight C, Rockwood K. Donepczil for treatment of dementia with Lewy bodies: a case series of nine patients, Int Psychogeriatr 1998;10(3):229-38.
9. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesberry WR. Brain infarction and the clinical expression of Alzheimer Disease. The Nun Study. JAMA 1997;277:813-7.
10. Forette F, Seux M-L, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51.
11. Brenner DE, Kukull WA, Stergachis A, Van Belle G, Bowen JD, McCormick WC, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study. Am J Epidemiol 1994;140:262-7.
12. Nilsson K, Palmerstierna T, Wistedt B. Aggressive behaviour in hospitalized psychogeriatric patients. Acta Psychiatr Scand 1998;78:172-5.
13. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia - a randomized, double-blind trial. J Clin Psychiatry 1999;60:107-15.